NASDAQ:GNOM Global X Genomics & Biotechnology ETF (GNOM) Price, Holdings, & News $11.72 +0.11 (+0.95%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$11.64▼$11.8750-Day Range$10.14▼$11.8052-Week Range$8.63▼$12.53Volume54,066 shsAverage Volume63,508 shsMarket Capitalization$86.73 millionAssets Under Management$86.46 millionDividend Yield0.00%Net Expense Ratio0.50% Stock AnalysisStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Get Global X Genomics & Biotechnology ETF alerts: Email Address About Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)Complete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.Read More GNOM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNOM ETF News HeadlinesJuly 25 at 10:54 PM | seekingalpha.comGNOM Global X Genomics & Biotechnology ETFMay 2, 2024 | investorplace.com3 Gene Editing Stocks with the Potential to Make You an Overnight MillionaireJuly 27, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.April 18, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On 10x GenomicsMarch 21, 2024 | investorplace.com3 Stocks That Could Be the Next Big Thing in Gene EditingMarch 14, 2024 | finance.yahoo.comGlobal X Genomics & Biotechnology UCITS ETF (GNOG.L)March 6, 2024 | investing.comGlobal X Genomics & Biotechnology ETF (GNOM)December 29, 2023 | msn.comGlobal X Cannabis ETF declares $0.1656 dividendJuly 27, 2024 | Weiss Ratings (Ad)Nvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.May 12, 2023 | investing.comGlobal X S&P 500® Catholic Values ETF (CATH)See More Headlines Receive GNOM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerGlobal X Fund NameGlobal X Genomics & Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:GNOM Inception Date4/5/2019 Fund ManagerChang Kim, James Ong, Nam To, Wayne Xie Webwww.completegenomics.com Phone+1-650-9432800Fund Focus Asset ClassEquity BenchmarkSolactive Genomics Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings45 Fund Statistics Assets Under Management$86.46 million Average Daily Volume$0.00 Discount/Premium-0.01% Administrator, Advisor and Custodian AdministratorGlobal X Management Company LLC AdvisorGlobal X Management Company LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerSusquehanna Options OptionableN/A Short Interest15,800 shs Miscellaneous Outstanding Shares7,400,000Beta1.03 Creation Unit50,000 Creation Fee$500.00 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Ad American Hartford Gold GroupPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Global X Genomics & Biotechnology ETF ExpensesTypeGNOMTheme ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.48%0.51%Other Expenses0.00%0.57%0.50%0.39%0.54%Total Expense0.50%0.73%0.70%0.61%0.71%Fee Waiver0.00%-0.74%-0.54%-0.32%-0.59%Net Expense0.50%0.59%0.60%0.54%0.58% Global X Genomics & Biotechnology ETF (GNOM) Holdings & ExposureTop 10 GNOM HoldingsAlnylam Pharmaceuticals(NASDAQ:ALNY)Holding Weight: 6.74%Avidity Biosciences(NASDAQ:RNA)Holding Weight: 5.41%Sarepta Therapeutics(NASDAQ:SRPT)Holding Weight: 4.60%Natera(NASDAQ:NTRA)Holding Weight: 4.55%Bio-Techne(NASDAQ:TECH)Holding Weight: 4.27%Arrowhead Pharmaceuticals(NASDAQ:ARWR)Holding Weight: 4.14%Myriad Genetics(NASDAQ:MYGN)Holding Weight: 4.08%Moderna(NASDAQ:MRNA)Holding Weight: 4.06%Intellia Therapeutics(NASDAQ:NTLA)Holding Weight: 3.94%Legend Biotech(NASDAQ:LEGN)Holding Weight: 3.94%GNOM Sector ExposureGNOM Industry ExposureFull Holdings Details Similar ETFsERShares Entrepreneurs ETFNASDAQ:ENTRTema Cardiovascular and Metabolics ETFNASDAQ:HRTSGlobal X Data Center & Digital Infrastructure ETFNASDAQ:DTCRiShares ESG Advanced MSCI EM ETFNASDAQ:EMXFFidelity Disruptors ETFNASDAQ:FDIFInstitutional OwnershipArchford Capital Strategies LLCBought 13,703 shares on 7/17/2024Ownership: 0.412%James J. Burns & Company LLCBought 17,255 shares on 7/17/2024Ownership: 0.193%Insight Advisors LLC PABought 7,861 shares on 7/16/2024Ownership: 0.236%Manhattan West Asset Management LLCSold 10,711 shares on 5/15/2024Ownership: 0.298%Banco Santander S.A.Sold 9,050 shares on 5/10/2024Ownership: 0.177%View All Institutional Transactions GNOM ETF - Frequently Asked Questions How have GNOM shares performed this year? Global X Genomics & Biotechnology ETF's stock was trading at $11.56 at the beginning of 2024. Since then, GNOM shares have increased by 1.4% and is now trading at $11.72. View the best growth stocks for 2024 here. Who are Global X Genomics & Biotechnology ETF's major shareholders? Global X Genomics & Biotechnology ETF's top institutional shareholders include Archford Capital Strategies LLC (0.41%), Insight Advisors LLC PA (0.24%) and James J. Burns & Company LLC (0.19%). How do I buy shares of Global X Genomics & Biotechnology ETF? Shares of GNOM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Global X Genomics & Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Global X Genomics & Biotechnology ETF investors own include Inovio Pharmaceuticals (INO), Gilead Sciences (GILD), Intel (INTC), Pfizer (PFE), Quest Diagnostics (DGX) and Micron Technology (MU). This page (NASDAQ:GNOM) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts